These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 34058148)

  • 1. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Radicioni G; Ceppe A; Ford AA; Alexis NE; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez FJ; Ozkan E; Paine R; Woodruff PG; O'Neal WK; Boucher RC; Kesimer M
    Lancet Respir Med; 2021 Nov; 9(11):1241-1254. PubMed ID: 34058148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway Mucin Concentration as a Marker of Chronic Bronchitis.
    Kesimer M; Ford AA; Ceppe A; Radicioni G; Cao R; Davis CW; Doerschuk CM; Alexis NE; Anderson WH; Henderson AG; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez F; Paine R; Woodruff PG; O'Neal WK; Boucher RC
    N Engl J Med; 2017 Sep; 377(10):911-922. PubMed ID: 28877023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease.
    Kirkham S; Kolsum U; Rousseau K; Singh D; Vestbo J; Thornton DJ
    Am J Respir Crit Care Med; 2008 Nov; 178(10):1033-9. PubMed ID: 18776153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of FEV
    Yee N; Markovic D; Buhr RG; Fortis S; Arjomandi M; Couper D; Anderson WH; Paine R; Woodruff PG; Han MK; Martinez FJ; Barr RG; Wells JM; Ortega VE; Hoffman EA; Kim V; Drummond MB; Bowler RP; Curtis JL; Cooper CB; Tashkin DP; Barjaktarevic IZ
    Chest; 2022 Apr; 161(4):949-959. PubMed ID: 34767825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ratio of FEV
    Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
    Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
    Paulin LM; Gassett AJ; Alexis NE; Kirwa K; Kanner RE; Peters S; Krishnan JA; Paine R; Dransfield M; Woodruff PG; Cooper CB; Barr RG; Comellas AP; Pirozzi CS; Han M; Hoffman EA; Martinez FJ; Woo H; Peng RD; Fawzy A; Putcha N; Breysse PN; Kaufman JD; Hansel NN;
    JAMA Intern Med; 2020 Jan; 180(1):106-115. PubMed ID: 31816012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.
    Woodruff PG; Barr RG; Bleecker E; Christenson SA; Couper D; Curtis JL; Gouskova NA; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Lazarus SC; Martinez FJ; Paine R; Rennard S; Tashkin DP; Han MK;
    N Engl J Med; 2016 May; 374(19):1811-21. PubMed ID: 27168432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbocisteine inhibits the expression of Muc5b in COPD mouse model.
    Song Y; Wang W; Xie Y; Xiang B; Huang X; Guan W; Zheng J
    Drug Des Devel Ther; 2019; 13():3259-3268. PubMed ID: 31571828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated Lung Function Decline and Mucus-Microbe Evolution in Chronic Obstructive Pulmonary Disease.
    Meldrum OW; Donaldson GC; Narayana JK; Ivan FX; Jaggi TK; Mac Aogáin M; Finney LJ; Allinson JP; Wedzicha JA; Chotirmall SH
    Am J Respir Crit Care Med; 2024 Aug; 210(3):298-310. PubMed ID: 38315959
    [No Abstract]   [Full Text] [Related]  

  • 14. Localization of Secretory Mucins MUC5AC and MUC5B in Normal/Healthy Human Airways.
    Okuda K; Chen G; Subramani DB; Wolf M; Gilmore RC; Kato T; Radicioni G; Kesimer M; Chua M; Dang H; Livraghi-Butrico A; Ehre C; Doerschuk CM; Randell SH; Matsui H; Nagase T; O'Neal WK; Boucher RC
    Am J Respir Crit Care Med; 2019 Mar; 199(6):715-727. PubMed ID: 30352166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.
    Henke MO; John G; Germann M; Lindemann H; Rubin BK
    Am J Respir Crit Care Med; 2007 Apr; 175(8):816-21. PubMed ID: 17255563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.
    Papi A; Hughes R; Del Olmo R; Agusti A; Chipps BE; Make B; Tomaszewski E; Peres Da Costa K; Srivastava D; Vestbo J; Janson C; Burgel PR; Price D
    Ther Adv Respir Dis; 2024; 18():17534666241254212. PubMed ID: 38841799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients.
    Caramori G; Casolari P; Di Gregorio C; Saetta M; Baraldo S; Boschetto P; Ito K; Fabbri LM; Barnes PJ; Adcock IM; Cavallesco G; Chung KF; Papi A
    Histopathology; 2009 Sep; 55(3):321-31. PubMed ID: 19723147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
    Pirozzi CS; Gu T; Quibrera PM; Carretta EE; Han MK; Murray S; Cooper CB; Tashkin DP; Kleerup EC; Barjaktarevic I; Hoffman EA; Martinez CH; Christenson SA; Hansel NN; Graham Barr R; Bleecker ER; Ortega VE; Martinez FJ; Kanner RE; Paine R;
    Respir Res; 2018 Nov; 19(1):223. PubMed ID: 30454050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS.
    Martinez CH; Diaz AA; Meldrum C; Curtis JL; Cooper CB; Pirozzi C; Kanner RE; Paine R; Woodruff PG; Bleecker ER; Hansel NN; Barr RG; Marchetti N; Criner GJ; Kazerooni EA; Hoffman EA; Ross BD; Galban CJ; Cigolle CT; Martinez FJ; Han MK;
    Am J Respir Crit Care Med; 2017 Feb; 195(4):464-472. PubMed ID: 27564413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.